☆ 4.5 Review

A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

ADVANCES IN THERAPY (2022)

Related references

Note: Only part of the references are listed.
Article Rheumatology

Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database

Peter C. Taylor et al.

Summary: This study reported long-term safety data of baricitinib in patients with active RA, including analysis of various adverse events and assessment of malignancy risk. The conclusions indicated that baricitinib maintained a stable safety profile similar to earlier analyses, with no new safety signals identified.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection
Article Rheumatology

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Farzin Khosrow-Khavar et al.

Summary: The study did not find evidence of increased cardiovascular risk with tofacitinib in patients with RA in a real-world setting. However, tofacitinib was associated with an increased risk of cardiovascular outcomes, although statistically non-significant, in patients with RA with cardiovascular risk factors.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection
Editorial Material Dermatology

Risk of herpesvirus, and serious and opportunistic infections in atopic dermatitis: population-based cohort study

[Anonymous]

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Review Immunology

Recent issues in JAK inhibitor safety: perspective for the clinician

Roy Fleischmann

Summary: This article examines the safety of five jakinibs compared to other medications and finds no significant differences in the risks of major adverse cardiac events, malignancy, venous thrombotic episodes, infections, and mortality in the safety databases and head-to-head studies. However, in a high-risk population, jakinibs are more likely to cause these adverse events. Therefore, the use of biologics should be considered before jakinibs in high-risk individuals.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)

Add to Collection
Review Immunology

The infection risks of JAK inhibition

Maryam A. Adas et al.

Summary: Licensed JAK inhibitors have shown increased risk of infection compared to placebo, affecting respiratory and urinary tracts, nasopharynx, and skin. This risk is dose-dependent and similar to that seen with biologic therapies. Other risk factors for infection, such as age and steroid co-prescription, further compound the risk.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)

Add to Collection
Article Medicine, General & Internal

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg et al.

Summary: In this trial comparing the use of tofacitinib with a TNF inhibitor in a cardiovascular risk-enriched population, the risks of major adverse cardiovascular events (MACE) and cancers were found to be higher with tofacitinib, and it did not meet noninferiority criteria. Several adverse events were more common with tofacitinib.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Article Medicine, General & Internal

Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort

Yuki M. F. Andersen et al.

Summary: This study aims to provide data on the current situation of patients with alopecia areata (AA) and serve as a reference for future research. The findings indicate that the average age of onset for AA is 32.7 years, and the majority of patients are Caucasian. Approximately 72.4% of patients received a diagnosis within one year after the onset of symptoms, and about 66.9% of patients still reported symptoms within the past year. Additionally, around 12% of patients reported having a first-degree family member with AA.

BMJ OPEN (2022)

Add to Collection
Article Critical Care Medicine

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial

E. Wesley Ely et al.

Summary: This study evaluated the efficacy and safety of baricitinib plus standard of care in critically ill COVID-19 patients. The results showed that compared to placebo, treatment with baricitinib significantly reduced mortality at both 28 and 60 days. Additionally, there were no significant differences in ventilator-free days and hospitalization duration between the baricitinib and placebo groups.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection
Article Medicine, General & Internal

Association Between Atopic Dermatitis, Asthma, and Serum Lipids: A UK Biobank Based Observational Study and Mendelian Randomization Analysis

Zhenwei Tang et al.

FRONTIERS IN MEDICINE (2022)

Add to Collection
Review Dermatology

Association between atopic dermatitis and hypertension: a systematic review and meta-analysis

M. Yousaf et al.

Summary: Previous studies have shown conflicting results about the association between atopic dermatitis and hypertension. This systematic review found that AD, particularly moderate-to-severe disease, was associated with increased hypertension compared with healthy controls, but with lower odds than for psoriasis. Hypertension was commonly reported as an adverse event secondary to AD treatments, particularly systemic ciclosporin A.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Article Dermatology

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)

Thomas Bieber et al.

Summary: This study demonstrated that baricitinib combined with background topical corticosteroids can provide sustained improvements in the signs and symptoms of moderate-to-severe atopic dermatitis for up to 1 year, particularly in patients who have contraindications or inadequate response to ciclosporin A. The most common treatment-emergent adverse events with baricitinib 4 mg were nasopharyngitis, herpes simplex, influenza, and headache, and the safety profile was consistent with previous studies in patients with moderate-to-severe atopic dermatitis.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Meeting Abstract Rheumatology

EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES

E. F. Morand et al.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection
Article Medicine, General & Internal

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani et al.

LANCET (2022)

Add to Collection
Article Dermatology

Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study

J. Wan et al.

Summary: Atopic dermatitis is significantly associated with herpesvirus infections, serious infections, and opportunistic infections, with the risk increasing with the severity of AD.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Article Rheumatology

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States

Robin K. Dore et al.

Summary: This study assessed the impact of comorbidities such as anemia, malignancy, VTE, MACE, and infections on treatment selection, persistency, and healthcare costs in patients with RA. The results showed that these comorbidities are associated with increased healthcare costs at all stages of the treatment journey.

ACR OPEN RHEUMATOLOGY (2022)

Add to Collection
Article Dermatology

Association of inflammatory skin diseases with venous thromboembolism in US adults

Mohammed S. Shaheen et al.

Summary: The study found that atopic dermatitis, pemphigus, and pemphigoid were associated with venous thromboembolism (VTE) and an increased risk of hospitalization for VTE in US adults. Patients with these inflammatory skin diseases may benefit from increased screening and prevention of VTE.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)

Add to Collection
Article Peripheral Vascular Disease

Microvascular dysfunction in COVID-19: the MYSTIC study

Alexandros Rovas et al.

Summary: Our study found that COVID-19 patients have reduced microvascular density, slower red blood cell velocity, and glycocalyx damage. Elevated markers of endothelial dysfunction are associated with disease severity and can predict 60-day in-hospital mortality.

ANGIOGENESIS (2021)

Add to Collection
Article Rheumatology

The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study

Lingyi Li et al.

Summary: This study reveals that patients with RA have an elevated risk of developing VTE, PE, and DVT compared to the general population after diagnosis, with the highest risk in the first year post-RA diagnosis followed by a gradual decline.

RHEUMATOLOGY (2021)

Add to Collection
Article Allergy

Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19

Jonathan T. Sims et al.

Summary: This study investigated circulating biomarkers in COVID-19 patients compared to healthy controls, revealing a hyperinflammatory environment and markers of vascular endothelial damage in patients. As the disease progresses, there is significant dysregulation of immune response proteins.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection
Article Dermatology

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

T. Bieber et al.

Summary: This study reports pooled safety data for baricitinib in patients with moderate-to-severe AD, confirming the established safety profile of baricitinib in this population.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Add to Collection
Review Rheumatology

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis

Jose Maria Pego-Reigosa et al.

Summary: The study found that patients with SLE have a significantly higher risk of infection compared to the general population/healthy controls, including overall severe infection, pneumonia, tuberculosis, and herpes zoster. Heterogeneity and evidence of publication bias were present in all analyses, except for herpes zoster, with sensitivity analysis confirming the robustness of the results.

RHEUMATOLOGY (2021)

Add to Collection
Review Hematology

Hematological Manifestations among Patients with Rheumatic Diseases

Alina Klein et al.

Summary: This review discusses cytopenias caused by systemic lupus erythematosus and antirheumatic drugs, Felty's syndrome in rheumatoid arthritis, and autoimmune hemolytic anemia, thrombosis, and thrombotic microangiopathies related to rheumatological conditions such as catastrophic antiphospholipid syndrome and scleroderma renal crisis. It emphasizes the importance of considering rheumatic autoimmune diseases in the differential diagnosis of various hematological disorders and the timely recognition and treatment of these presentations by hematologists.

ACTA HAEMATOLOGICA (2021)

Add to Collection
Article Dermatology

Comorbidities of alopecia areata: a population-based cohort study

A. Egeberg et al.

Summary: The study showed that AA patients had a higher risk of developing comorbidities such as vitiligo, atopic dermatitis, and Crohn disease, with many comorbidities occurring prior to AA diagnosis.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)

Add to Collection
Review Rheumatology

Risk of venous thromboembolism in rheumatoid arthritis

Chahinez Ketfi et al.

Summary: Rheumatoid arthritis patients have a more than double risk of venous thromboembolism compared with the general population, potentially due to activation of Virchow's triad components. Factors such as surgery, uncontrolled RA, and biological DMARDs may increase the incidence of VTE.

JOINT BONE SPINE (2021)

Add to Collection
Article Dermatology

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

Marjolein de Bruin-Weller et al.

Summary: The EUROSTAD study enrolled 308 adult patients with moderate-to-severe AD, with an average age of 37 years and a disease duration of 25 years. Most patients used systemic therapy and experienced high disease severity and burden, as well as borderline or clinical levels of anxiety and/or depression.

JOURNAL OF DERMATOLOGICAL TREATMENT (2021)

Add to Collection
Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

COVID-19 and thrombosis: From bench to bedside

Mohammad A. M. Ali et al.

Summary: COVID-19 is a respiratory viral infection caused by the coronavirus SARS-CoV2, which has been found to increase the risk of venous and arterial thromboembolic events. There is growing attention from the scientific community on the link between COVID-19 and thrombosis.

TRENDS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection
Article Dermatology

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Brett King et al.

Summary: The study evaluated the efficacy and safety of baricitinib in patients with alopecia areata. The results showed that baricitinib was effective in patients with >= 50% scalp hair loss and well tolerated, supporting its use in this patient population.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Thrombosis and Coagulopathy in COVID-19

Juan Esteban Gomez-Mesa et al.

Summary: Since the outbreak of COVID-19 in Wuhan in December 2019, the virus has spread globally, leading to a pandemic declaration by the World Health Organization. Hospitalized patients with severe COVID-19 who have comorbidities and abnormal coagulation function are at higher risk of poor prognosis, while early anticoagulant treatment with low molecular weight heparin has been shown to significantly reduce mortality rates.

CURRENT PROBLEMS IN CARDIOLOGY (2021)

Add to Collection
Article Rheumatology

Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs

Arthur Kavanaugh et al.

Summary: The long-term use of filgotinib for the treatment of rheumatoid arthritis, either with or without methotrexate, showed good safety and efficacy with ACR20/50/70 responses maintained over 4 years, comparable to the parent trials.

JOURNAL OF RHEUMATOLOGY (2021)

Add to Collection
Article Dermatology

Baricitinib in patients with moderate-tosevere atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

Eric L. Simpson et al.

Summary: The study evaluated the efficacy and safety of baricitinib monotherapy in patients with moderate-to-severe AD who responded inadequately or were intolerant to topical therapy. Results showed a higher proportion of patients achieving efficacy endpoints in the baricitinib groups at week 16.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection
Review Rheumatology

Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis

Ann E. Clarke et al.

Summary: The risk of overall malignancies and some site-specific malignancies is increased in patients with systemic lupus erythematosus compared to the general population. However, the risk for some site-specific malignancies is decreased or does not differ. Further research on risk profiles and patient phenotypes may help in reducing malignancy risk.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Add to Collection
Article Medicine, Research & Experimental

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

Athimalaipet Ramanan et al.

Summary: This study represents the first pediatric clinical trial to evaluate the clinical efficacy and safety of a JAK inhibitor in JIA-uveitis or chronic ANA-positive uveitis. A novel Bayesian design is being used to assess the effectiveness of baricitinib, with an adalimumab reference arm, in this small patient population with unmet medical needs.

TRIALS (2021)

Add to Collection
Review Medicine, General & Internal

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

Peter C. Taylor et al.

Summary: Comorbidities in patients with rheumatoid arthritis are often associated with poor health outcomes and increased mortality. It is important to balance potential treatment benefits against the risks of comorbidities and consider prevention or treatment of comorbidities as part of the overall management of RA. As newer therapies are developed and patients gain access to advanced treatments, including biosimilars, there is a need to explore the impact of comorbidities on patient outcomes and the interplay with therapeutic options.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete

Irini Gergianaki et al.

Summary: This study analyzed the comorbidity patterns of patients with systemic lupus erythematosus, revealing a high prevalence of both physical and mental comorbidities among these patients. Sociodemographic and clinical factors were independently associated with the presence of multimorbidity. The results emphasize the need for integrated care to optimize outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection
Article Dermatology

Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral

Alexander Egeberg et al.

Summary: This study investigated the long-term drug utilization patterns and healthcare consumption among Danish patients with atopic dermatitis. The results showed that a large proportion of patients used potent topical corticosteroids at their first visit, and received better treatment after referral.

DERMATOLOGY AND THERAPY (2021)

Add to Collection
Article Medicine, General & Internal

Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series

Matthew Harries et al.

Summary: This study aims to investigate the epidemiology of alopecia areata (AA) and its associations with mental health, autoimmune/atopic conditions, and common infections using a large population-based cohort. The study will examine the prevalence and treatment patterns of mental health conditions, autoimmune/atopic associations, and common infections in individuals with AA compared to matched controls. Results will be disseminated through peer-reviewed publications.

BMJ OPEN (2021)

Add to Collection
Article Allergy

Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response

Axel P. Villani et al.

Summary: The study found significant correlations between vascular inflammation and Th2-related products in the skin and blood of AD patients, as well as atherosclerosis-related markers modulated by dupilumab. Circulating levels of endothelial microparticles were significantly higher in severe AD patients and tended to correlate with vascular inflammation.

ALLERGY (2021)

Add to Collection
Article Dermatology

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials

Brett King et al.

Summary: This study evaluated the safety of baricitinib 2 mg in treating moderate-to-severe AD, and found that treatment-emergent adverse events were higher with the drug compared to placebo, but serious adverse events were low and similar between the two groups. The integrated analysis confirmed the established safety profile of baricitinib 2 mg in patients with AD, but longer exposure to treatment is needed to assess the risks of malignancies and major adverse cardiovascular events.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Alopecia areata is not a risk factor for heart diseases: A 10-year retrospective cohort study

Heera Lee et al.

Summary: The study concluded that alopecia areata does not increase the risk of heart diseases, regardless of the severity or duration of the disease.

PLOS ONE (2021)

Add to Collection
Article Dermatology

Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database

Kristin J. Meyers et al.

Summary: This study found that the risk of venous thromboembolism (VTE) is low among patients with atopic dermatitis (AD), and AD is not an independent risk factor for VTE. While the risk of VTE was slightly higher in patients with moderate-to-severe AD compared to non-AD controls, this difference disappeared after adjustments for healthcare use and VTE risk factors.

DERMATOLOGY AND THERAPY (2021)

Add to Collection
Article Dermatology

27523 Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis (AD) from the phase 2 and phase 3 clinical trial program

Eric L. Simpson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection
Article Dermatology

26585 Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis

Amy Paller et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection
Article Dermatology

Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases

Maria C. Schneeweiss et al.

Summary: In this large-scale cohort study, chronic inflammatory skin diseases (CISDs) were not found to be associated with an increased incidence of venous thromboembolism (VTE) after controlling for relevant VTE risk factors in a representative dermatology patient population.

JAMA DERMATOLOGY (2021)

Add to Collection
Review Pharmacology & Pharmacy

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

Shahin Shams et al.

Summary: Rheumatoid arthritis is a debilitating autoimmune disease with serious consequences, and despite advancements in treatment, many patients still have inadequate response or intolerable side effects. New pharmacological treatments and bioengineering approaches are being explored to improve therapy for this systemic autoimmune disease.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Article Critical Care Medicine

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial

Vincent C. Marconi et al.

Summary: Although there was no significant reduction in the frequency of disease progression overall, treatment with baricitinib in addition to standard of care (including dexamethasone) had a similar safety profile to that of standard care alone, and was associated with reduced mortality in hospitalised adults with COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection
Review Peripheral Vascular Disease

COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on Two-Path Unifying Theory of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy

Jae C. Chang

Summary: COVID-19 sepsis leads to ARDS primarily due to viral pulmonary tropism and host endothelial cell heterogeneity. Endothelial cell dysfunction causes inflammation and microthrombus formation, resulting in sepsis-associated microthrombotic disease.

VASCULAR HEALTH AND RISK MANAGEMENT (2021)

Add to Collection
Article Rheumatology

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

Stanley B. Cohen et al.

Summary: In the phase III clinical trials for RA, patients treated with upadacitinib at 15 mg and 30 mg doses had higher rates of upper respiratory tract infection, nasopharyngitis, and urinary tract infection compared to those on methotrexate and adalimumab. Serious infection rates were similar between upadacitinib 15 mg and adalimumab, but higher than methotrexate, while rates of herpes zoster and CPK elevations were higher with both upadacitinib doses. Rates of deaths, malignancies, MACEs, and VTEs were similar across all treatment groups.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection
Article Allergy

Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents

Federico Carbone et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Add to Collection
Review Rheumatology

Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Siddharth Singh et al.

ARTHRITIS CARE & RESEARCH (2020)

Add to Collection
Article Rheumatology

Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study

Rabia Agca et al.

JOURNAL OF RHEUMATOLOGY (2020)

Add to Collection
Article Rheumatology

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial

Jon T. Giles et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Add to Collection
Article Dermatology

Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients

M. Seegraeber et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Add to Collection
Article Dermatology

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany

A. Heratizadeh et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Add to Collection
Article Dermatology

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

E. L. Simpson et al.

BRITISH JOURNAL OF DERMATOLOGY (2020)

Add to Collection
Article Allergy

Eczema Herpeticum: Clinical and Pathophysiological Aspects

Alexia Damour et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Add to Collection
Article Dermatology

Association of Atopic Dermatitis With Bacterial, Fungal, Viral, and Sexually Transmitted Skin Infections

Ziyou Ren et al.

DERMATITIS (2020)

Add to Collection
Article Hematology

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection
Review Immunology

Risk Factors for Herpes Zoster Infection: A Meta-Analysis

Fawziah Marra et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

Add to Collection
Article Medicine, Research & Experimental

Mechanism of baricitinib supports artificial intelligence-predicted testing inCOVID-19 patients

Justin Stebbing et al.

EMBO MOLECULAR MEDICINE (2020)

Add to Collection
Review Dermatology

Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis A Systematic Review and Meta-analysis

Lily Wang et al.

JAMA DERMATOLOGY (2020)

Add to Collection
Article Rheumatology

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Kevin L. Winthrop et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Add to Collection
Article Immunology

JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells

Yuya Fujita et al.

BMC IMMUNOLOGY (2020)

Add to Collection
Article Dermatology

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Maryam M. Asgari et al.

JAMA DERMATOLOGY (2020)

Add to Collection
Article Dermatology

Association Between Atopic Eczema and Cancer in England and Denmark

Kathryn E. Mansfield et al.

JAMA DERMATOLOGY (2020)

Add to Collection
Article Medicine, General & Internal

Atopic dermatitis

Sinéad M Langan et al.

LANCET (2020)

Add to Collection
Letter Medicine, General & Internal

Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome

Adeline Vanderver et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Article Dermatology

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial

Kristian Reich et al.

JAMA DERMATOLOGY (2020)

Add to Collection
Article Rheumatology

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

Stanley B. Cohen et al.

RMD OPEN (2020)

Add to Collection
Article Rheumatology

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

Jonathan Kay et al.

RMD OPEN (2020)

Add to Collection
Article Immunology

Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases

Zoltan Szekanece et al.

AUTOIMMUNITY REVIEWS (2020)

Add to Collection
Article Rheumatology

Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment

Annette de Thurah et al.

RMD OPEN (2020)

Add to Collection
Review Dermatology

Comorbidities in alopecia areata: A systematic review and meta-analysis

Solam Lee et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Add to Collection
Article Rheumatology

Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study

Seoyoung C. Kim et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)

Add to Collection
Review Rheumatology

Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials

Wenhui Xie et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Add to Collection
Review Rheumatology

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Antonis Fanouriakis et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Add to Collection
Review Cell Biology

Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions

Aleksandra Korniluk et al.

MEDIATORS OF INFLAMMATION (2019)

Add to Collection
Article Medicine, General & Internal

Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients

Gregory Katz et al.

MAYO CLINIC PROCEEDINGS (2019)

Add to Collection
Review Dermatology

Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis

Linda Serrano et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Add to Collection
Review Rheumatology

Clinical significance of Janus Kinase inhibitor selectivity

Ernest H. Choy

RHEUMATOLOGY (2019)

Add to Collection
Article Rheumatology

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis

Peter C. Taylor et al.

ARTHRITIS & RHEUMATOLOGY (2019)

Add to Collection
Article Rheumatology

Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study

Bella Mehta et al.

RMD OPEN (2019)

Add to Collection
Article Rheumatology

Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations

Iain B. McInnes et al.

ARTHRITIS RESEARCH & THERAPY (2019)

Add to Collection
Article Rheumatology

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

Huifang Liang et al.

RMD OPEN (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study

Alexis Ogdie et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection
Review Rheumatology

Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective

Masayoshi Harigai

MODERN RHEUMATOLOGY (2018)

Add to Collection
Article Allergy

Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults

Shanthi Narla et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

Add to Collection
Article Rheumatology

Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies

Peter C. Taylor et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

Add to Collection
Letter Dermatology

Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations

J. P. Thyssen et al.

BRITISH JOURNAL OF DERMATOLOGY (2018)

Add to Collection
Article Hematology

Pathogenesis and diagnosis of disseminated intravascular coagulation

M. Levi

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2018)

Add to Collection
Article Medicine, Research & Experimental

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

Gina A. Montealegre Sanchez et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection
Article Medicine, General & Internal

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Daniel J. Wallace et al.

LANCET (2018)

Add to Collection
Article Transplantation

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

Katherine R. Tuttle et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)

Add to Collection
Review Rheumatology

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis

Roxanne Cooksey et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)

Add to Collection
Article Rheumatology

Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis

Kim Lauper et al.

ARTHRITIS CARE & RESEARCH (2018)

Add to Collection
Article Multidisciplinary Sciences

Cancer risk by the subtype of alopecia

Ji Hyun Lee et al.

SCIENTIFIC REPORTS (2018)

Add to Collection
Article Medicine, General & Internal

Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study

Richard J. Silverwood et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Add to Collection
Article Medicine, General & Internal

Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study

Richard J. Silverwood et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Add to Collection
Article Oncology

Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study

Chih-Chiang Chen et al.

CANCER MEDICINE (2018)

Add to Collection
Review Dermatology

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders

Amy Paller et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)

Add to Collection
Review Medicine, General & Internal

Relationship of atopic dermatitis with stroke and myocardial infarction A meta-analysis

Min Yuan et al.

MEDICINE (2018)

Add to Collection
Article Allergy

Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis

A. Egeberg et al.

ALLERGY (2017)

Add to Collection
Article Rheumatology

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

A. Strangfeld et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection
Article Rheumatology

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?

Jonas K. Eriksson et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection
Article Rheumatology

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Maxime Dougados et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection
Article Rheumatology

Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study

J. Halskou Hesselvig et al.

LUPUS (2017)

Add to Collection
Article Dermatology

Association of Atopic Dermatitis with Cardiovascular Risk Factors and Diseases

Marie Standl et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Add to Collection
Article Dermatology

Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

Patrick M. Brunner et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Add to Collection
Review Dermatology

JAK inhibitors in dermatology: The promise of a new drug class

William Damsky et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Add to Collection
Article Rheumatology

Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study

O. Ahlehoff et al.

LUPUS (2017)

Add to Collection
Article Medicine, General & Internal

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

Peter C. Taylor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Article Rheumatology

Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study

Kensuke Kume et al.

RHEUMATOLOGY INTERNATIONAL (2017)

Add to Collection
Article Rheumatology

Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study

J. Antonio Avina-Zubieta et al.

ARTHRITIS CARE & RESEARCH (2017)

Add to Collection
Article Medicine, General & Internal

Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice A Nationwide Cohort Study From Sweden

Hjalmar Wadstroem et al.

JAMA INTERNAL MEDICINE (2017)

Add to Collection
Article Rheumatology

Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

Medha Barbhaiya et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Add to Collection
Article Rheumatology

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

Roy Fleischmann et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Add to Collection
Article Endocrinology & Metabolism

The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin

Leila N. Varghese et al.

FRONTIERS IN ENDOCRINOLOGY (2017)

Add to Collection
Review Rheumatology

A review on SLE and malignancy

May Y. Choi et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)

Add to Collection
Article Rheumatology

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis

Katelynn M. Wilton et al.

RHEUMATOLOGY AND THERAPY (2017)

Add to Collection
Article Biochemistry & Molecular Biology

Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice

Zaicun Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection
Review Rheumatology

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

Sofia Ramiro et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection
Article Dermatology

Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma

Yuki M. F. Andersen et al.

CURRENT DERMATOLOGY REPORTS (2017)

Add to Collection
Article Rheumatology

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries

Johan Askling et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Add to Collection
Review Rheumatology

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

Daniella M. Schwartz et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Add to Collection
Article Dermatology

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis

K. A. Papp et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Add to Collection
Article Oncology

Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study

Arash Mostaghimi et al.

CANCER EPIDEMIOLOGY (2016)

Add to Collection
Letter Allergy

Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis

Yuki M. F. Andersen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection
Article Dermatology

Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis

Sara Gandini et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2016)

Add to Collection
Article Rheumatology

Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study

Yoshiya Tanaka et al.

JOURNAL OF RHEUMATOLOGY (2016)

Add to Collection
Article Dermatology

Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis

Kathie P. Huang et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Add to Collection
Article Medicine, General & Internal

Baricitinib in Patients with Refractory Rheumatoid Arthritis

Mark C. Genovese et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection
Review Rheumatology

Dyslipidemia in systemic lupus erythematosus: just another comorbidity?

Konstantinos Tselios et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)

Add to Collection
Review Rheumatology

Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

Christina Charles-Schoeman et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)

Add to Collection
Article Medicine, General & Internal

Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study

Jette Lindorff Riis et al.

BMJ OPEN (2016)

Add to Collection
Article Rheumatology

Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases Implications for Vaccination

Huifeng Yun et al.

ARTHRITIS & RHEUMATOLOGY (2016)

Add to Collection
Article Rheumatology

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

Andrea Rubbert-Roth et al.

RMD OPEN (2016)

Add to Collection
Article Medicine, General & Internal

Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs

Seoyoung C. Kim et al.

AMERICAN JOURNAL OF MEDICINE (2015)

Add to Collection
Review Rheumatology

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Camille Roubille et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Add to Collection
Review Rheumatology

Malignancies in systemic lupus erythematosus: a 2015 update

Gillian C. Goobie et al.

CURRENT OPINION IN RHEUMATOLOGY (2015)

Add to Collection
Review Rheumatology

Management of neutropenia in patients with rheumatoid arthritis

Estibaliz Lazaro et al.

JOINT BONE SPINE (2015)

Add to Collection
Article Dermatology

The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

Florence J. Dalgard et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Add to Collection
Article Rheumatology

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Camille Roubille et al.

JOURNAL OF RHEUMATOLOGY (2015)

Add to Collection
Review Dermatology

Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis

Laureline Legendre et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Add to Collection
Review Cardiac & Cardiovascular Systems

Epidemiology of venous thromboembolism

John A. Heit

NATURE REVIEWS CARDIOLOGY (2015)

Add to Collection
Review Rheumatology

The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study

J. Antonio Avina-Zubieta et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)

Add to Collection
Article Hematology

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees

Hussain R. Yusuf et al.

THROMBOSIS RESEARCH (2015)

Add to Collection
Article Multidisciplinary Sciences

Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study

Jiunn-Horng Kang et al.

SCIENTIFIC REPORTS (2015)

Add to Collection
Article Rheumatology

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

Edward C. Keystone et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Add to Collection
Article Rheumatology

Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis

Patompong Ungprasert et al.

RHEUMATOLOGY (2015)

Add to Collection
Article Rheumatology

Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis

Teresa A. Simon et al.

ARTHRITIS RESEARCH & THERAPY (2015)

Add to Collection
Article Rheumatology

Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions

Hanna Johnsson et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Add to Collection
Article Rheumatology

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Maxime Dougados et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Add to Collection
Letter Dermatology

Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009

Sultan A. Mirzoyev et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Add to Collection
Article Hematology

Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study

W. -S. Chung et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Add to Collection
Article Rheumatology

A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases

Jason J. Lee et al.

ARTHRITIS RESEARCH & THERAPY (2014)

Add to Collection
Article Rheumatology

A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort

Rachael L. Gross et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Add to Collection
Article Rheumatology

Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

Kevin L. Winthrop et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Add to Collection
Article Rheumatology

The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study

Hyon K. Choi et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Add to Collection
Review Medicine, Research & Experimental

Mechanisms of Premature Atherosclerosis in Rheumatoid Arthritis and Lupus

J. Michelle Kahlenberg et al.

ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)

Add to Collection
Article Allergy

Mental health comorbidity in patients with atopic dermatitis

Pouya Yaghmaie et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Add to Collection
Article Rheumatology

Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies

A. Danza et al.

LUPUS (2013)

Add to Collection
Review Rheumatology

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

Joachim Listing et al.

RHEUMATOLOGY (2013)

Add to Collection
Article Rheumatology

Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis

Seoyoung C. Kim et al.

ARTHRITIS CARE & RESEARCH (2013)

Add to Collection
Article Dermatology

Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated With Alopecia Areata in the United States

Kathie P. Huang et al.

JAMA DERMATOLOGY (2013)

Add to Collection
Article Dermatology

Atopic Dermatitis and Risk of Skin Cancer A Danish Nationwide Cohort Study (1977-2006)

Annette O. Jensen et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)

Add to Collection
Article Rheumatology

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

Juan Antonio Avina-Zubieta et al.

ANNALS OF THE RHEUMATIC DISEASES (2012)

Add to Collection
Article Rheumatology

Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?

A. Kirstin Bacani et al.

ARTHRITIS AND RHEUMATISM (2012)

Add to Collection
Article Medicine, General & Internal

Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization

Marie E. Holmqvist et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Add to Collection
Article Hematology

Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study

S. A. Johannesdottir et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

Add to Collection
Article Cell Biology

Targeting Cancer with a Lupus Autoantibody

James E. Hansen et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Add to Collection
Article Rheumatology

Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis

Jeffrey R. Curtis et al.

ARTHRITIS CARE & RESEARCH (2012)

Add to Collection
Article Rheumatology

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Rebecca Davies et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Add to Collection
Article Rheumatology

Longitudinal Predictors of Progression of Carotid Atherosclerosis in Rheumatoid Arthritis

Jon T. Giles et al.

ARTHRITIS AND RHEUMATISM (2011)

Add to Collection
Review Rheumatology

Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

Taras Gout et al.

CLINICAL RHEUMATOLOGY (2011)

Add to Collection
Review Immunology

Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention

Maureen McMahon et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)

Add to Collection
Article Allergy

Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response

Donald Y. M. Leung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Add to Collection
Article Rheumatology

Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease

Carlos Gonzalez-Juanatey et al.

ARTHRITIS RESEARCH & THERAPY (2011)

Add to Collection
Review Allergy

The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma

Tao Zheng et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2011)

Add to Collection
Article Rheumatology

Is the Incidence of Rheumatoid Arthritis Rising? Results From Olmsted County, Minnesota, 1955-2007

Elena Myasoedova et al.

ARTHRITIS AND RHEUMATISM (2010)

Add to Collection
Article Dermatology

Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.

A. Arana et al.

BRITISH JOURNAL OF DERMATOLOGY (2010)

Add to Collection
Review Biochemistry & Molecular Biology

Oxidative stress, inflammation, and cancer How are they linked?

Simone Reuter et al.

FREE RADICAL BIOLOGY AND MEDICINE (2010)

Add to Collection
Article Immunology

Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050

Jordan S. Fridman et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection
Article Rheumatology

A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract

Francis K. L. Chan et al.

JOURNAL OF RHEUMATOLOGY (2010)

Add to Collection
Article Hematology

Mean platelet volume is a risk factor for venous thromboembolism: the Troms circle divide study

S. K. Braekkan et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Add to Collection
Review Rheumatology

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

Daniel E. Furst

SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)

Add to Collection
Review Rheumatology

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

E. Choy et al.

ANNALS OF THE RHEUMATIC DISEASES (2009)

Add to Collection
Article Allergy

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum

Lisa A. Beck et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Add to Collection
Review Dermatology

Atopic Dermatitis: A Disease Caused by Innate Immune Defects?

Anna De Benedetto et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

Add to Collection
Article Rheumatology

Thrombosis in Systemic Lupus Erythematosus and Other Autoimmune Diseases of Recent Onset

Juanita Romero-Diaz et al.

JOURNAL OF RHEUMATOLOGY (2009)

Add to Collection
Article Immunology

DMARDS and infections in rheumatoid arthritis

Roberto Caporali et al.

AUTOIMMUNITY REVIEWS (2008)

Add to Collection
Article Surgery

Incidence of perforated diverticulitis and risk factors for death in a UK population

C. R. Morris et al.

BRITISH JOURNAL OF SURGERY (2008)

Add to Collection
Article Rheumatology

Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus

Mary J. Roman et al.

ARTHRITIS AND RHEUMATISM (2007)

Add to Collection
Review Dermatology

Atopic dermatitis and cancer risk

H Wang et al.

BRITISH JOURNAL OF DERMATOLOGY (2006)

Add to Collection
Article Medicine, General & Internal

Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients

R Cervera et al.

MEDICINE (2003)

Add to Collection
Article Cardiac & Cardiovascular Systems

The epidemiology of venous thromboembolism

RH White

CIRCULATION (2003)

Add to Collection
Article Rheumatology

Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study

MF Doran et al.

ARTHRITIS AND RHEUMATISM (2002)

Add to Collection
Article Rheumatology

Predictors of infection in rheumatoid arthritis

MF Doran et al.

ARTHRITIS AND RHEUMATISM (2002)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.